Xufang Deng

发表

Structure-based design of SARS-CoV-2 papain-like protease inhibitors.

R. Jedrzejczak, C. Tesar, J. Osipiuk, 2023, European journal of medicinal chemistry.

Naturally Occurring Mutations of SARS-CoV-2 Main Protease Confer Drug Resistance to Nirmatrelvir

Hao Tan, Yu Chen, Yanmei Hu, 2023, ACS central science.

Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model

Bin Tan, Jun Wang, Kan Li, 2024, Science.